Specialist manufacturer of gastrointestinal products, Given Imaging Ltd. (NASDAQ:GIVN) confirmed the success of its PillCam ESO to support triage patients with upper gastrointestinal bleeding (UGIB). It also revealed details pertaining to Bravo Systems, indicating that it can increase patient pH monitoring up to four days for those who suffer from gastroesophageal reflux disease (GERD). The announcements are supported by clinical trials and data from reputed universities across the globe.
According … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards